Sheikh Shakhbout’s Bold New Partnerships
Sheikh Shakhbout Medical City (SSMC) has taken a major step forward in…
PHRMAG appoints new Executive Committee for 2025–2027
Dubai, UAE- February 2025- The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG)…
WHO issues alert on falsified IMFINZI injection in multiple countries
December 2024- The World Health Organization (WHO) has issued a medical product…
AstraZeneca appoints Iskra Reic as EVP to lead international markets
December 2024- AstraZeneca announced the appointment of Iskra Reic as Executive Vice…
‘‘We Are Shifting From A Reactive To Preventive Approach In Healthcare’’ – Pelin Incesu
AstraZeneca is making a significant impact in the Middle East and Africa…
AstraZeneca Advances Cancer Care Standards at WCLC and ESMO 2024
AstraZeneca advances its ambition to revolutionise cancer care with new data across…
Fasenra Approved in China for Severe Eosinophilic Asthma
China's National Medical Products Association (NMPA) has approved AstraZeneca’s Fasenra (benralizumab) for…
Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
BenevolentAI, AstraZeneca Collaboration Hits New Milestone
London- June 2024: BenevolentAI announces that AstraZeneca has added a novel target…
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030
May 2024- AstraZeneca revealed its bold ambition to deliver $80 billion in…